News
December 2025
Labflow will continue to operate as a standalone technology company, retaining our existing team, leadership and brand. With the backing of Magentus’s global scale and deep healthcare expertise, we are strengthening our ability to deliver innovative, customer-focused solutions at pace.
Enhanced capability. Labflow’s modern, cloud-native workflow tools will be united with Magentus’ trusted clinical and diagnostic platforms, creating a more powerful and integrated ecosystem for laboratory and healthcare operations.
Accelerated innovation. The partnership enables us to accelerate delivery across our roadmap, including advanced solutions for genomic laboratories, enhanced inventory management and ongoing expansion of LabMaster, our class-leading laboratory information management platform.
Scalable impact. With deployments already supporting millions of tests and continued international expansion, Labflow enhances Magentus’s pathology portfolio by providing seamless access to a suite of future-ready, modular software solutions designed for high-volume, multi-site environments.
Our customers will continue to benefit from the same reliable products, exceptional service and dedicated Labflow team they know today. This partnership reinforces our long-term commitment to making pathology smarter, faster and more connected, while providing the resources and stability needed to support sustained growth and innovation.
This is an exciting evolution for Labflow, and we look forward to delivering even greater value to our customers and partners in the years ahead.